Matches in Wikidata for { <http://www.wikidata.org/entity/Q81732280> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q81732280 description "article scientifique publié en 2008" @default.
- Q81732280 description "artículu científicu espublizáu n'ochobre de 2008" @default.
- Q81732280 description "scientific article published on 01 October 2008" @default.
- Q81732280 description "wetenschappelijk artikel" @default.
- Q81732280 description "наукова стаття, опублікована в жовтні 2008" @default.
- Q81732280 name "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 name "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 type Item @default.
- Q81732280 label "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 label "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 prefLabel "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 prefLabel "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 P1433 Q81732280-7B919783-6BAB-4B18-AEDB-525970612F25 @default.
- Q81732280 P1476 Q81732280-2E8644E9-6E90-427D-9717-88D5B9F3B6B2 @default.
- Q81732280 P2093 Q81732280-222BDD1E-A229-4B3C-883A-3058EDA41364 @default.
- Q81732280 P2093 Q81732280-82E1DC05-751B-4FEB-A182-855AEE984324 @default.
- Q81732280 P2093 Q81732280-B329A757-77CA-45D4-8891-7C6D547970CA @default.
- Q81732280 P304 Q81732280-4C4A5380-C021-40BC-8390-CB54C6CB99C6 @default.
- Q81732280 P31 Q81732280-59786BDF-FE1B-4D34-83AC-A70CE2BC8721 @default.
- Q81732280 P356 Q81732280-152D6B1D-4250-465A-94D9-B689D735813E @default.
- Q81732280 P433 Q81732280-1B71D70A-5FD7-4112-BF2B-DA48D52AC586 @default.
- Q81732280 P478 Q81732280-615D451F-EF67-41BB-84E9-B811EC4053BF @default.
- Q81732280 P577 Q81732280-1A0C600A-2E03-4D09-9F3C-982235509A84 @default.
- Q81732280 P698 Q81732280-B5E0D191-36B5-423F-AC41-F66441AFD98A @default.
- Q81732280 P921 Q81732280-93D44512-FB6B-4DC6-A3BD-57FF88844561 @default.
- Q81732280 P356 J.JBSPIN.2008.01.026 @default.
- Q81732280 P698 18674944 @default.
- Q81732280 P1433 Q15752403 @default.
- Q81732280 P1476 "Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy" @default.
- Q81732280 P2093 "Daniel Wendling" @default.
- Q81732280 P2093 "Evelyne Racadot" @default.
- Q81732280 P2093 "Jean-Pierre Cedoz" @default.
- Q81732280 P304 "559-562" @default.
- Q81732280 P31 Q13442814 @default.
- Q81732280 P356 "10.1016/J.JBSPIN.2008.01.026" @default.
- Q81732280 P433 "5" @default.
- Q81732280 P478 "75" @default.
- Q81732280 P577 "2008-10-01T00:00:00Z" @default.
- Q81732280 P698 "18674944" @default.
- Q81732280 P921 Q52849 @default.